Jefferson University Hospitals

Provider Profile

A.M. Rostami, MD, PhD

Jefferson University Physician

Academic Title: Professor
Chair, Department of Neurology

Neurology - Neuroimmunology

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

909 Walnut Street
2nd Floor, COB Bldg.
Philadelphia PA 19107
Fax: (215) 955-1234
Fax: (215) 955-1390

Medical Services

Board Certifications

  • Neurology

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital
  • Methodist Hospital Division of Thomas Jefferson University Hospital


Subspecialty is Multiple Sclerosis


  • Shiraz University, Medical School


  • Hospital of the University of Pennsylvania


  • Hospital of the University of Pennsylvania

Jefferson physicians accept most health insurance plans, including those listed below. However, plan acceptance may vary by practice and may be subject to change. If you have questions about whether a specific physician accepts your insurance, please contact your insurance company.

Insurances Accepted

  • Aetna
  • Aetna PA Employee Benefit Trust Fund (PEBTF)
  • AmeriHealth
  • Amerihealth Caritas
  • AmeriHealth Comprehensive
  • AmeriHealth HMO
  • AmeriHealth Personal Choice
  • Blue Cross/Blue Shield
  • Cigna Healthspring
  • Cigna PPO, POS
  • Consumer Health Network PPO
  • CorVel
  • Devon
  • Employers Health Network PPO
  • Evolutions (Guardian Resources)
  • Federal BCBS
  • Geisinger Health Plan
  • Health America PPO
  • Health Management Network PPO
  • Horizon Blue Cross/Blue Shield
  • HumanaChoicePPO,Medicare,GoldPlusHMO
  • Jeff Plus
  • Keystone 65 HMO
  • Keystone First VIP Choice
  • Keystone First/Connect
  • Keystone Health Plan East
  • Medicaid of PA
  • Medicare
  • Mercy LIFE
  • MultiPlan Inc.
  • NJ Plus
  • Personal Choice (GPPPN)
  • Personal Choice 65
  • PlanCare America
  • Preferred Care PPO
  • Premier Blue
  • Prime Health Services, Inc.
  • Qualcare
  • Tricare
  • United Healthcare
  • UPMC HMO,PPO ReadingHspEmpONLY
  • UPMC Medicare HMO
  • US Family Health Plan


Recent Publications

Elevated expression of granulocyte-macrophage colony-stimulating factor receptor in multiple sclerosis lesions

Interaction of RNA-binding protein HuR and miR-466i regulates GM-CSF expression

DAB389IL-2 recombinant fusion toxin effect on lymphocyte- and macrophage-producing cytokine subpopulation cells in experimentally induced demyelinating disease in mice

Induction of peripheral tolerance in ongoing autoimmune inflammation requires interleukin 27 signaling in dendritic cells

LINGO-1-Fc-Transduced Neural Stem Cells Are Effective Therapy for Chronic Stage Experimental Autoimmune Encephalomyelitis

LPS-treated bone marrow-derived dendritic cells induce immune tolerance through modulating differentiation of CD4+regulatory T cell subpopulations mediated by 3G11 and CD127

1,25-Dihydroxyvitamin D3suppressed experimental autoimmune encephalomyelitis through both immunomodulation and oligodendrocyte maturation

Effect of Fingolimod on Neural Stem Cells: A Novel Mechanism and Broadened Application for Neural Repair

CpG Type A Induction of an Early Protective Environment in Experimental Multiple Sclerosis

Prevalence of multiple sclerosis in Iranian emigrants: review of the evidence

Selective depletion of CD11c+CD11b+dendritic cells partially abrogates tolerogenic effects of intravenous MOG in murine EAE

Neural Stem Cells Engineered to Express Three Therapeutic Factors Mediate Recovery from Chronic Stage CNS Autoimmunity

Galectin-1 is essential for the induction of MOG35–55-based intravenous tolerance in experimental autoimmune encephalomyelitis

IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis

Apoptotic cell-treated dendritic cells induce immune tolerance by specifically inhibiting development of CD4+ effector memory T cells

IL-9 signaling affects central nervous system resident cells during inflammatory stimuli

Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway

Emerging immunopharmacological targets in multiple sclerosis

1,25-Dihydroxyvitamin D3enhances neural stem cell proliferation and oligodendrocyte differentiation

Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- And tissue-specific microRNAs